Skip to main content
OpenTrials

Clinical trial condition

Nodal Marginal Zone Lymphoma

Explore clinical trials studying Nodal Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

17 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Nodal Marginal Zone Lymphoma trial results

Completed

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

NCT00253630

Conditions
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma

NCT01701232

Conditions
Follicular Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Instituto Nacional de Cancerología Bogotá, Colombia
  • Fundación Reina Isabel Cali, Colombia
  • Hospital Pablo Tobon Uribe Medellín, Colombia
  • HCG Multi Specialty Hospitals Ahmedabad, India
View all 62 locations
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms

NCT00082784

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Active, Not Recruiting

MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

NCT03697512

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • CHU UCL Namur / site Godinne Yvoir, Belgium
  • CHU de Tours - Hôpital Bretonneau Tours, Cedex 01, France
  • CHU de Montpellier Montpellier, Cedex 05, France
  • CHU d'Estaing Clermont-Ferrand, Cedex 1, France
View all 36 locations
View Trial Details

Related conditions